• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Autoimmune sensorineural hearing loss as presenting manifestation of paediatric Behçet disease responding to adalimumab: a case report.自身免疫性感音神经性听力损失作为儿童贝赫切特病的首发表现且对阿达木单抗有反应:一例报告
Ital J Pediatr. 2016 Sep 6;42(1):81. doi: 10.1186/s13052-016-0291-2.
2
Behçet's disease presenting as a peripheral vestibulopathy.贝赫切特病表现为周围前庭病。
J Clin Neurosci. 2014 Jun;21(6):1060-3. doi: 10.1016/j.jocn.2013.08.021. Epub 2013 Oct 30.
3
Successful treatment with adalimumab for autoimmune sensorineural hearing loss in a patient with Behçet's disease.阿达木单抗成功治疗一名白塞病患者的自身免疫性感音神经性听力损失。
Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):164-165. Epub 2019 Jul 11.
4
Autoimmune inner ear disease (AIED): A diagnostic challenge.自身免疫性内耳疾病(AIED):诊断难题。
Int J Immunopathol Pharmacol. 2018 Mar-Dec;32:2058738418808680. doi: 10.1177/2058738418808680.
5
Adalimumab in the treatment of pediatric Behçet's disease: case-based review.阿达木单抗治疗儿童贝赫切特病:基于病例的综述。
Rheumatol Int. 2019 Jun;39(6):1107-1112. doi: 10.1007/s00296-019-04300-0. Epub 2019 Apr 11.
6
Successful treatment with adalimumab in a familial case of gastrointestinal Behcet's disease.阿达木单抗治疗家族性胃肠道贝赫切特病 1 例。
J Crohns Colitis. 2011 Aug;5(4):364-8. doi: 10.1016/j.crohns.2011.03.006. Epub 2011 Apr 27.
7
[Sudden deafness and Behçet's disease].
Acta Otorhinolaryngol Belg. 1989;43(3):221-9.
8
Sensorineural hearing loss and ulcerative colitis.
J Laryngol Otol. 1997 Mar;111(3):277-8. doi: 10.1017/s0022215100137077.
9
[Otorhinolaryngological manifestations in patients with Behçet disease].[白塞病患者的耳鼻喉科表现]
Acta Otorrinolaringol Esp. 2014 Jan-Feb;65(1):15-21. doi: 10.1016/j.otorri.2013.06.007. Epub 2013 Oct 2.
10
Adalimumab treatment for life threatening pulmonary artery aneurysm in Behçet disease: a case report.阿达木单抗治疗 Behçet 病致死性肺动脉瘤:一例报告。
Clin Rheumatol. 2010 Jan;29(1):91-3. doi: 10.1007/s10067-009-1272-2. Epub 2009 Oct 9.

引用本文的文献

1
Infliximab for the Treatment of Inflammatory Labyrinthitis: A Retrospective Cohort Study.英夫利昔单抗治疗炎性迷路炎:一项回顾性队列研究
J Clin Med. 2023 Jun 28;12(13):4350. doi: 10.3390/jcm12134350.
2
Treatment with Biologic Drugs in Pediatric Behçet's Disease: A Comprehensive Analysis of the Published Data.儿童贝赫切特病的生物药物治疗:已发表数据的综合分析。
BioDrugs. 2023 Nov;37(6):813-828. doi: 10.1007/s40259-023-00613-6. Epub 2023 Jun 29.
3
Cerebrovascular involvement in systemic childhood vasculitides.系统性儿童血管炎的脑血管受累。
Clin Rheumatol. 2023 Oct;42(10):2733-2746. doi: 10.1007/s10067-023-06552-5. Epub 2023 Mar 8.
4
Construction of an MRI-based decision tree to differentiate autoimmune and autoinflammatory inner ear disease from chronic otitis media with sensorineural hearing loss.基于 MRI 的决策树构建,用于区分自身免疫性和自身炎症性内耳疾病与伴有感音神经性听力损失的慢性中耳炎。
Sci Rep. 2021 Sep 27;11(1):19171. doi: 10.1038/s41598-021-98557-w.
5
[Advances in diagnosis and therapies of immune-mediated inner ear diseases].免疫介导性内耳疾病的诊断与治疗进展
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Mar;34(3):276-281. doi: 10.13201/j.issn.2096-7993.2020.03.023.
6
Adalimumab in the treatment of pediatric Behçet's disease: case-based review.阿达木单抗治疗儿童贝赫切特病:基于病例的综述。
Rheumatol Int. 2019 Jun;39(6):1107-1112. doi: 10.1007/s00296-019-04300-0. Epub 2019 Apr 11.
7
Update on Vertigo in Autoimmune Disorders, from Diagnosis to Treatment.自身免疫性疾病性眩晕:从诊断到治疗的最新进展
J Immunol Res. 2018 Sep 26;2018:5072582. doi: 10.1155/2018/5072582. eCollection 2018.
8
Autoimmune inner ear disease secondary to Hashimoto's thyroiditis: a case report.继发于桥本甲状腺炎的自身免疫性内耳疾病:一例报告
J Community Hosp Intern Med Perspect. 2018 Aug 23;8(4):227-229. doi: 10.1080/20009666.2018.1503917. eCollection 2018.
9
Optimal management of Cogan's syndrome: a multidisciplinary approach.科根综合征的优化管理:多学科方法
J Multidiscip Healthc. 2017 Dec 22;11:1-11. doi: 10.2147/JMDH.S150940. eCollection 2018.
10
Cochlear Impairment and Autoimmune Ear Disorder in a Patient with Breast Cancer.一名乳腺癌患者的耳蜗损伤与自身免疫性耳病
Audiol Res. 2017 Mar 13;7(1):165. doi: 10.4081/audiores.2017.165. eCollection 2017 Feb 1.

本文引用的文献

1
Consensus classification criteria for paediatric Behçet's disease from a prospective observational cohort: PEDBD.儿科贝赫切特病的共识分类标准:PEDBD。
Ann Rheum Dis. 2016 Jun;75(6):958-64. doi: 10.1136/annrheumdis-2015-208491. Epub 2015 Dec 23.
2
Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients.抗 TNF-α 在严重和/或难治性贝赫切特病中的疗效:124 例患者的多中心研究。
J Autoimmun. 2015 Aug;62:67-74. doi: 10.1016/j.jaut.2015.06.005. Epub 2015 Jul 8.
3
[Otorhinolaryngological manifestations in patients with Behçet disease].[白塞病患者的耳鼻喉科表现]
Acta Otorrinolaringol Esp. 2014 Jan-Feb;65(1):15-21. doi: 10.1016/j.otorri.2013.06.007. Epub 2013 Oct 2.
4
The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria.国际白塞病诊断标准(ICBD):27 个国家对新标准敏感性和特异性的合作研究。
J Eur Acad Dermatol Venereol. 2014 Mar;28(3):338-47. doi: 10.1111/jdv.12107. Epub 2013 Feb 26.
5
Autoimmune sensorineural hearing loss: the otology-rheumatology interface.自身免疫性感音神经性听力损失:耳科学-风湿病学的交叉领域。
Rheumatology (Oxford). 2013 May;52(5):780-9. doi: 10.1093/rheumatology/ket009. Epub 2013 Feb 21.
6
Adalimumab for the treatment of Behçet's disease: experience in 19 patients.阿达木单抗治疗白塞病:19 例患者的经验。
Rheumatology (Oxford). 2012 Oct;51(10):1825-31. doi: 10.1093/rheumatology/kes130. Epub 2012 Jun 20.
7
HLA-B*51 and Behçet Disease.HLA-B*51 与白塞病。
Ocul Immunol Inflamm. 2012 Feb;20(1):37-43. doi: 10.3109/09273948.2011.634978. Epub 2011 Dec 21.
8
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease.白塞病的管理:欧洲抗风湿病联盟关于白塞病管理的循证推荐的系统文献综述
Ann Rheum Dis. 2009 Oct;68(10):1528-34. doi: 10.1136/ard.2008.087957. Epub 2008 Apr 17.
9
Hearing loss and middle ear involvement in patients with juvenile idiopathic arthritis.幼年特发性关节炎患者的听力损失与中耳受累情况
Int J Pediatr Otorhinolaryngol. 2007 Jul;71(7):1079-85. doi: 10.1016/j.ijporl.2007.03.017. Epub 2007 May 4.
10
[Epidemiology and clinical manifestations of Adamantiades-Behçet disease in Germany -- current pathogenetic concepts and therapeutic possibilities].德国白塞病的流行病学与临床表现——当前的发病机制概念及治疗可能性
J Dtsch Dermatol Ges. 2006 Jan;4(1):49-64; quiz 65-6. doi: 10.1111/j.1610-0387.2006.05841.x.

自身免疫性感音神经性听力损失作为儿童贝赫切特病的首发表现且对阿达木单抗有反应:一例报告

Autoimmune sensorineural hearing loss as presenting manifestation of paediatric Behçet disease responding to adalimumab: a case report.

作者信息

Marsili Manuela, Marzetti Valentina, Lucantoni Marta, Lapergola Giuseppe, Gattorno Marco, Chiarelli Francesco, Breda Luciana

机构信息

Department of Pediatrics, University of Chieti, Via dei Vestini 5, Chieti, 66100, Italy.

UO Pediatria II, G. Gaslini Scientific Institute, Genova, Italy.

出版信息

Ital J Pediatr. 2016 Sep 6;42(1):81. doi: 10.1186/s13052-016-0291-2.

DOI:10.1186/s13052-016-0291-2
PMID:27600159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5011950/
Abstract

BACKGROUND

Autoimmune sensorineural hearing loss, also known as autoimmune inner ear disease (AIED) is a rare clinical entity characterized by progressive and bilateral sensorineural hearing loss often accompanied by vestibular symptoms. Diagnosis is essential as a consistent number of patients show a positive response to steroids alone or in association with other immunosuppressive drugs. AIED is defined as primary when the disease is limited to the ear, whereas in up to a third of cases it is associated to other systemic autoimmune diseases such as Behçet disease (BD). BD is a rare multisystem vasculitis characterized by recurrent oral and genital aphtosis, uveitis, skin lesions, neurological and vascular manifestations. Clinical presentation is variable thus making the diagnosis difficult in many instances. The choice of therapy is also limited by the scarceness of high-quality therapy studies.

CASE PRESENTATION

We present a 15-year-old-boy with six months of history of fever, dizziness, tinnitus and ataxia. He had a final diagnosis of AIED associated to BD and was successfully treated with the anti-tumor necrosis factor (TNF)-α adalimumab.

CONCLUSIONS

This case report points out to the diagnostic and therapeutic challenges of BD especially when unusual symptoms are the prominent manifestations of the disease. It also suggests that adalimumab is a good therapeutic option in children with BD and audiovestibular symptoms.

摘要

背景

自身免疫性感音神经性听力损失,也称为自身免疫性内耳疾病(AIED),是一种罕见的临床病症,其特征为进行性双侧感音神经性听力损失,常伴有前庭症状。诊断至关重要,因为相当数量的患者单独使用类固醇或与其他免疫抑制药物联合使用时显示出阳性反应。当疾病仅限于耳部时,AIED被定义为原发性,而在高达三分之一的病例中,它与其他全身性自身免疫性疾病如白塞病(BD)相关。BD是一种罕见的多系统血管炎,其特征为复发性口腔和生殖器溃疡、葡萄膜炎、皮肤病变、神经和血管表现。临床表现多变,因此在许多情况下难以诊断。治疗选择也受到高质量治疗研究稀缺的限制。

病例报告

我们报告一名15岁男孩,有6个月的发热、头晕、耳鸣和共济失调病史。他最终被诊断为与BD相关的AIED,并通过抗肿瘤坏死因子(TNF)-α阿达木单抗成功治疗。

结论

本病例报告指出了BD的诊断和治疗挑战,尤其是当不寻常症状是该疾病的突出表现时。它还表明阿达木单抗是患有BD和视听前庭症状儿童的一种良好治疗选择。